Phase II trial of nilotinib as third-line therapy for gastrointestinal stromal tumor (GIST) patients in Japan.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 10015-10015 ◽  
Author(s):  
T. Nishida ◽  
A. Sawaki ◽  
T. Doi ◽  
Y. Yamada ◽  
Y. Komatsu ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumor ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Stromal Tumor ◽  
Line Therapy ◽  
Third Line Therapy ◽  
Third Line

scholarly journals Phase II trial of biweekly cetuximab and irinotecan as third‐line therapy for pretreated KRAS exon 2 wild‐type colorectal cancer

2018 ◽  
Vol 109 (8) ◽  
pp. 2567-2575 ◽  
Author(s):  
Hiroki Osumi ◽  
Eiji Shinozaki ◽  
Tetsuo Mashima ◽  
Takeru Wakatsuki ◽  
Mitsukuni Suenaga ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Wild Type ◽  
Exon 2 ◽  
Line Therapy ◽  
Third Line Therapy ◽  
Third Line ◽  
Kras Exon

A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesothelioma

Lung Cancer ◽  
2020 ◽  
Vol 140 ◽  
pp. 87-92 ◽  
Author(s):  
Wei-Sen Lam ◽  
Jenette Creaney ◽  
Fred K. Chen ◽  
Wee Loong Chin ◽  
Sanjeevan Muruganandan ◽  
...  
Keyword(s):  
Phase Ii ◽  
Malignant Pleural Mesothelioma ◽  
Phase Ii Trial ◽  
Pleural Mesothelioma ◽  
Line Therapy ◽  
Third Line Therapy ◽  
Third Line

Phase 2 study of nilotinib as third-line therapy for patients with gastrointestinal stromal tumor

Cancer ◽  
2011 ◽  
Vol 117 (20) ◽  
pp. 4633-4641 ◽  
Author(s):  
Akira Sawaki ◽  
Toshirou Nishida ◽  
Toshihiko Doi ◽  
Yasuhide Yamada ◽  
Yoshito Komatsu ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumor ◽  
Stromal Tumor ◽  
Phase 2 ◽  
Line Therapy ◽  
Phase 2 Study ◽  
Third Line Therapy ◽  
Third Line

scholarly journals Regorafenib as second line therapy for imatinib-resistant gastrointestinal stromal tumor (GIST): A phase II study

2019 ◽  
Vol 30 ◽  
pp. vi88
Author(s):  
Yoichi Naito ◽  
Toshihiko Doi ◽  
Tsuyoshi Takahashi ◽  
Toshihiro Kudo ◽  
Narikazu Boku ◽  
...  
Keyword(s):  
Gastrointestinal Stromal Tumor ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Stromal Tumor ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy ◽  
Imatinib Resistant
Sign in / Sign up

Export Citation Format

Share Document